Related articles

• Article

  Combination of CD19 and CD22 CAR-T cell therapy in relapsed B-cell acute lymphoblastic leukemia after allogeneic transplantation.

  Am. J. Hematol. 2021 Jun 1; 96 (6): 671-679.

• Randomized Controlled Trial

  Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies.

  Lancet. 2020 Dec 12; 396 (10266): 188518941885-1894.

• Meta Analysis

  Anti-CD19 chimeric antigen receptor T-cell therapy in acute lymphocytic leukaemia: a systematic review and meta-analysis.

  Lancet Haematol. 2020 Nov 1; 7 (11): e816-e826.

Show more related articles...